Aurobindo Pharma is a pharmaceutical company that focuses on the research, development, manufacturing, and marketing of active pharmaceutical ingredients and generic pharmaceuticals. The company’s products can be categorized into two main families: generic drugs and active pharmaceutical ingredients. The generic drugs offered by Aurobindo Pharma are used to treat a wide range of diseases, including neurological, cardiovascular, viral, gastroenterological, ophthalmologic, and chronic diseases.
As of March 2018, Aurobindo Pharma operated a total of 23 production sites across three countries: India, the United States, and Brazil. The majority of these production sites, 19, are located in India, while the remaining four are split between the United States, with three sites, and Brazil, with one site. This global presence enables the company to manufacture and supply its products to various markets around the world.
In terms of its sales, Aurobindo Pharma generates revenue from several geographic regions. The company’s net sales are distributed as follows: 12% from India, 46.5% from the United States, 31.2% from Europe, and 10.3% from other regions. This indicates that the United States is the company’s largest market, accounting for nearly half of its total sales. Europe is also a significant market for Aurobindo Pharma, contributing over 30% to the company’s net sales.
Overall, Aurobindo Pharma is a major player in the pharmaceutical industry, with a diverse portfolio of products and a global presence. The company’s focus on generic drugs and active pharmaceutical ingredients has enabled it to establish a strong position in the market, with a significant presence in several geographic regions. With its extensive network of production sites and diverse sales distribution, Aurobindo Pharma is well-positioned to continue growing and expanding its operations in the future. The company’s commitment to research, development, and manufacturing has enabled it to become a leading provider of affordable and high-quality pharmaceuticals to patients around the world.